...
首页> 外文期刊>Journal of Neuroscience Research >D-Serine metabolism in C6 glioma cells: Involvement of alanine-serine-cysteine transporter (ASCT2) and serine racemase (SRR) but not D-amino acid oxidase (DAO).
【24h】

D-Serine metabolism in C6 glioma cells: Involvement of alanine-serine-cysteine transporter (ASCT2) and serine racemase (SRR) but not D-amino acid oxidase (DAO).

机译:C6胶质瘤细胞中的D-丝氨酸代谢:涉及丙氨酸-丝氨酸-半胱氨酸转运蛋白(ASCT2)和丝氨酸消旋酶(SRR),但不涉及D-氨基酸氧化酶(DAO)。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

D-serine is an endogenous N-methyl-D-aspartate (NMDA) receptor coagonist. It is synthesized from L-serine by serine racemase (SRR), but many aspects of its metabolism remain unclear, especially in the forebrain, which lacks active D-amino acid oxidase (DAO), the major D-serine degradative enzyme. Candidate mechanisms include SRR operating in alpha,beta-eliminase mode (converting D-serine to pyruvate) and regulation by serine transport, in which the alanine-serine-cysteine transporter ASCT2 is implicated. Here we report studies in C6 glioma cells, which "simulate" the forebrain, in that the cells express SRR and ASCT2 but lack DAO activity. We measured D-serine, ASCT2, SRR, and DAO expression and DAO activity in two situations: after incubation of cells for 48 hr with serine isomers and after increased or decreased SRR expression by transfection and RNA interference, respectively. Incubation with serine enantiomers decreased [(3)H]D-serine uptake and ASCT2 mRNA and increased SRR immunoreactivity but did not alter DAO immunoreactivity, and DAO activity remained undetectable. SRR overexpression increased D-serine and pyruvate and decreased [(3)H]D-serine uptake and ASCT2 mRNA but did not affect DAO. SRR knockdown did not alter any of the parameters. Our data suggest that D-serine transport mediated by ASCT2 contributes prominently to D-serine homeostasis when DAO activity is absent. The factors regulating D-serine are important for understanding normal NMDA receptor function and because D-serine, along with DAO and SRR, is implicated in the pathogenesis and treatment of schizophrenia.
机译:D-丝氨酸是一种内源性N-甲基-D-天冬氨酸(NMDA)受体激动剂。它是通过丝氨酸消旋酶(SRR)从L-丝氨酸合成的,但其代谢的许多方面仍不清楚,特别是在前脑中,后者缺乏活性D-丝氨酸降解酶(DAO)。候选机制包括以α,β-消除酶模式运行的SRR(将D-丝氨酸转化为丙酮酸)和丝氨酸转运的调控,其中涉及丙氨酸-丝氨酸-半胱氨酸转运蛋白ASCT2。在这里,我们报告了“模拟”前脑的C6胶质瘤细胞的研究,这些细胞表达SRR和ASCT2但缺乏DAO活性。我们在两种情况下测量了D-丝氨酸,ASCT2,SRR和DAO的表达以及DAO的活性:分别用转染和RNA干扰将细胞与丝氨酸异构体孵育48小时后,SRR的表达增加或减少。与丝氨酸对映异构体一起孵育可降低[(3)H] D-丝氨酸摄取和ASCT2 mRNA并增加SRR免疫反应性,但没有改变DAO免疫反应性,并且DAO活性仍然不可检测。 SRR过表达增加D-丝氨酸和丙酮酸和减少[(3)H] D-丝氨酸摄取和ASCT2 mRNA,但不影响DAO。 SRR组合式没有改变任何参数。我们的数据表明,当DAO活性缺失时,由ASCT2介导的D-丝氨酸转运对D-丝氨酸的体内平衡起着重要作用。调节D-丝氨酸的因素对于理解正常的NMDA受体功能很重要,因为D-丝氨酸与DAO和SRR一起参与了精神分裂症的发病和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号